Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
68,652,138
-
Total 13F shares
-
14,560,311
-
Share change
-
+10,881,463
-
Total reported value
-
$14,686,745
-
Put/Call ratio
-
7.3%
-
Price per share
-
$0.98
-
Number of holders
-
46
-
Value change
-
+$11,049,642
-
Number of buys
-
21
-
Number of sells
-
18
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q1 2025
As of 31 Mar 2025,
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,560,311 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Nantahala Capital Management, LLC, Opaleye Management Inc., BIOS Capital Management, LP, VANGUARD GROUP INC, Mink Brook Asset Management LLC, Bleichroeder LP, AWM Investment Company, Inc., GEODE CAPITAL MANAGEMENT, LLC, and ROYAL BANK OF CANADA.
This page lists
46
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.